These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 11320368)
21. Serum uric acid correlates with extracellular superoxide dismutase activity in patients with chronic heart failure. Alcaino H; Greig D; Chiong M; Verdejo H; Miranda R; Concepcion R; Vukasovic JL; Diaz-Araya G; Mellado R; Garcia L; Salas D; Gonzalez L; Godoy I; Castro P; Lavandero S Eur J Heart Fail; 2008 Jul; 10(7):646-51. PubMed ID: 18559296 [TBL] [Abstract][Full Text] [Related]
22. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052 [TBL] [Abstract][Full Text] [Related]
23. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Anker SD; Leyva F; Poole-Wilson PA; Kox WJ; Stevenson JC; Coats AJ Heart; 1997 Jul; 78(1):39-43. PubMed ID: 9290400 [TBL] [Abstract][Full Text] [Related]
24. Non-invasive blood pressure variability in chronic heart failure: characteristics and prognostic value. Gibelin P; Spillner E; Bonnan S; Chevallier T Arch Mal Coeur Vaiss; 2003 Oct; 96(10):955-62. PubMed ID: 14653055 [TBL] [Abstract][Full Text] [Related]
25. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure. Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753 [TBL] [Abstract][Full Text] [Related]
26. Disturbance of circulating ghrelin and obestatin in chronic heart failure patients especially in those with cachexia. Xin X; Ren AJ; Zheng X; Qin YW; Zhao XX; Yuan WJ; Guo ZF Peptides; 2009 Dec; 30(12):2281-5. PubMed ID: 19666068 [TBL] [Abstract][Full Text] [Related]
27. Elevated levels of asymmetric dimethylarginine in chronic heart failure: a pathophysiologic link between oxygen radical load and impaired vasodilator capacity and the therapeutic effect of allopurinol. von Haehling S; Bode-Böger SM; Martens-Lobenhoffer J; Rauchhaus M; Schefold JC; Genth-Zotz S; Karhausen T; Cicoira M; Anker SD; Doehner W Clin Pharmacol Ther; 2010 Oct; 88(4):506-12. PubMed ID: 20827268 [TBL] [Abstract][Full Text] [Related]
29. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Kistorp C; Faber J; Galatius S; Gustafsson F; Frystyk J; Flyvbjerg A; Hildebrandt P Circulation; 2005 Sep; 112(12):1756-62. PubMed ID: 16157772 [TBL] [Abstract][Full Text] [Related]
30. Diagnostic and prognostic value of uric acid in patients with acute dyspnea. Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335 [TBL] [Abstract][Full Text] [Related]
31. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure. Jankowska EA; Filippatos G; Ponikowska B; Borodulin-Nadzieja L; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P J Card Fail; 2009 Jun; 15(5):442-50. PubMed ID: 19477405 [TBL] [Abstract][Full Text] [Related]
32. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. Davos CH; Doehner W; Rauchhaus M; Cicoira M; Francis DP; Coats AJ; Clark AL; Anker SD J Card Fail; 2003 Feb; 9(1):29-35. PubMed ID: 12612870 [TBL] [Abstract][Full Text] [Related]
33. Reduced peripheral skeletal muscle mass and abnormal reflex physiology in chronic heart failure. Piepoli MF; Kaczmarek A; Francis DP; Davies LC; Rauchhaus M; Jankowska EA; Anker SD; Capucci A; Banasiak W; Ponikowski P Circulation; 2006 Jul; 114(2):126-34. PubMed ID: 16818813 [TBL] [Abstract][Full Text] [Related]
35. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers. Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792 [TBL] [Abstract][Full Text] [Related]
36. Is uric acid itself a player or a bystander in the pathophysiology of chronic heart failure? Duan X; Ling F Med Hypotheses; 2008; 70(3):578-81. PubMed ID: 17689199 [TBL] [Abstract][Full Text] [Related]
37. Fibrinogen synthesis is increased in cachectic patients with chronic heart failure. Witte KK; Ford SJ; Preston T; Parker JD; Clark AL Int J Cardiol; 2008 Oct; 129(3):363-7. PubMed ID: 18022259 [TBL] [Abstract][Full Text] [Related]
38. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels. Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978 [TBL] [Abstract][Full Text] [Related]
39. Effects of short-term moderate exercise training on sexual function in male patients with chronic stable heart failure. Belardinelli R; Lacalaprice F; Faccenda E; Purcaro A; Perna G Int J Cardiol; 2005 May; 101(1):83-90. PubMed ID: 15860388 [TBL] [Abstract][Full Text] [Related]
40. Plasma adiponectin in heart failure with and without cachexia: catabolic signal linking catabolism, symptomatic status, and prognosis. Szabó T; Scherbakov N; Sandek A; Kung T; von Haehling S; Lainscak M; Jankowska EA; Rudovich N; Anker SD; Frystyk J; Flyvbjerg A; Pfeiffer AF; Doehner W Nutr Metab Cardiovasc Dis; 2014 Jan; 24(1):50-6. PubMed ID: 23791298 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]